Prucalopride
- Level
- Commodity
- Parent
- 51171600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171642This classification denotes a serotonin agonist with the molecular formula C18H26ClN3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0A09IUW5TP, chemically known as 4-amino-5-chloro-2,3-dihydro-n-(1-(3-methoxypropyl)-4-piperidyl)-7-benzofurancarboxamide but generally known as prucalopride, which bears US NIH Compound Identifier 3052762. European Medicines Agency schedules Prucalopride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10155MIG. The term PRUCALOPRIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 2 1999, List 40). World Health Organization schedules prucalopride in its Anatomical Therapeutic Chemical (ATC) Classification. PRUCALOPRIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule prucalopride under HS 29349990 and SITC 51579. As of Q4 2014, PRUCALOPRIDE remains the US FDA Preferred Term for this commodity. Prucalopride bears US NLM identifiers UMLS ID C0913506 and NCI Concept Code C74386. SMILES: CLC1CC(C(=O)NC2CCN(CC2)CCCOC)C2OCCC2C1N.
Same parent
Under 51171600 · 42Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.